THYQUIDITY
Live / Registered — Registered (as of 01 Feb 2022)
What this means for you
Registered since 01 Feb 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Feb 2028: the §8 declaration of use).
Record
- Serial number
- 88945650
- Registration number
- 6634369
- Mark type
- Word mark
- Filed
- 03 Jun 2020
- Published for opposition
- 13 Apr 2021
- Registered
- 01 Feb 2022
- Next maintenance filing
- §8 declaration of use, due by 01 Feb 2028 (grace period to 01 Aug 2028)
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency and thyroid cancer
Owner
- JEROME STEVENS PHARMACEUTICALS, INC., BOHEMIA, NY, US
- AZURITY PHARMACEUTICALS, INC., WOBURN, MA, US
- VistaPharm, Inc., New Providence, NJ, US
- VistaPharm, Inc., New Providence, NJ, US
- VistaPharm, Inc., New Providence, NJ, US
Prosecution history
- 11 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 10 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Oct 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Oct 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Oct 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Oct 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Aug 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 01 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Dec 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Dec 2021 — USE AMENDMENT FILED
- 29 Dec 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL